ReviewNature reviews. Gastroenterology & hepatology2011
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.
Mark S Sulkowski et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
59 papers cite it
this paperpooled ittrialcites it